These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 25145933)

  • 1. Inactivation of integrin-β1 prevents the development of polycystic kidney disease after the loss of polycystin-1.
    Lee K; Boctor S; Barisoni LM; Gusella GL
    J Am Soc Nephrol; 2015 Apr; 26(4):888-95. PubMed ID: 25145933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The regulation of cystogenesis in a tissue engineered kidney disease system by abnormal matrix interactions.
    Subramanian B; Ko WC; Yadav V; DesRochers TM; Perrone RD; Zhou J; Kaplan DL
    Biomaterials; 2012 Nov; 33(33):8383-94. PubMed ID: 22940218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cGAS Activation Accelerates the Progression of Autosomal Dominant Polycystic Kidney Disease.
    Yoo M; Haydak JC; Azeloglu EU; Lee K; Gusella GL
    J Am Soc Nephrol; 2024 Apr; 35(4):466-482. PubMed ID: 38247039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dnajb11-Kidney Disease Develops from Reduced Polycystin-1 Dosage but not Unfolded Protein Response in Mice.
    Ghosh Roy S; Li Z; Guo Z; Long KT; Rehrl S; Tian X; Dong K; Besse W
    J Am Soc Nephrol; 2023 Sep; 34(9):1521-1534. PubMed ID: 37332102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive development of polycystic kidney disease in the mouse model expressing Pkd1 extracellular domain.
    Kurbegovic A; Trudel M
    Hum Mol Genet; 2013 Jun; 22(12):2361-75. PubMed ID: 23439951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in the timing and magnitude of Pkd1 gene deletion determine the severity of polycystic kidney disease in an orthologous mouse model of ADPKD.
    Rogers KA; Moreno SE; Smith LA; Husson H; Bukanov NO; Ledbetter SR; Budman Y; Lu Y; Wang B; Ibraghimov-Beskrovnaya O; Natoli TA
    Physiol Rep; 2016 Jun; 4(12):. PubMed ID: 27356569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional TFEB activation characterizes multiple models of renal cystic disease and loss of polycystin-1.
    Shillingford JM; Shayman JA
    Am J Physiol Renal Physiol; 2023 Apr; 324(4):F404-F422. PubMed ID: 36794754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute kidney injury induces hallmarks of polycystic kidney disease.
    Kurbegovic A; Trudel M
    Am J Physiol Renal Physiol; 2016 Oct; 311(4):F740-F751. PubMed ID: 27488998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polycystin-1: a master regulator of intersecting cystic pathways.
    Fedeles SV; Gallagher AR; Somlo S
    Trends Mol Med; 2014 May; 20(5):251-60. PubMed ID: 24491980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular matrix, integrins, and focal adhesion signaling in polycystic kidney disease.
    Zhang Y; Reif G; Wallace DP
    Cell Signal; 2020 Aug; 72():109646. PubMed ID: 32311505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrosis and progression of autosomal dominant polycystic kidney disease (ADPKD).
    Norman J
    Biochim Biophys Acta; 2011 Oct; 1812(10):1327-36. PubMed ID: 21745567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated TGFbeta-Smad signalling in experimental Pkd1 models and human patients with polycystic kidney disease.
    Hassane S; Leonhard WN; van der Wal A; Hawinkels LJ; Lantinga-van Leeuwen IS; ten Dijke P; Breuning MH; de Heer E; Peters DJ
    J Pathol; 2010 Sep; 222(1):21-31. PubMed ID: 20549648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease.
    Shillingford JM; Murcia NS; Larson CH; Low SH; Hedgepeth R; Brown N; Flask CA; Novick AC; Goldfarb DA; Kramer-Zucker A; Walz G; Piontek KB; Germino GG; Weimbs T
    Proc Natl Acad Sci U S A; 2006 Apr; 103(14):5466-71. PubMed ID: 16567633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial Vasopressin Type-2 Receptors Regulate Myofibroblasts by a YAP-CCN2-Dependent Mechanism in Polycystic Kidney Disease.
    Dwivedi N; Tao S; Jamadar A; Sinha S; Howard C; Wallace DP; Fields TA; Leask A; Calvet JP; Rao R
    J Am Soc Nephrol; 2020 Aug; 31(8):1697-1710. PubMed ID: 32554753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic reduction of cilium length by targeting intraflagellar transport 88 protein impedes kidney and liver cyst formation in mouse models of autosomal polycystic kidney disease.
    Shao L; El-Jouni W; Kong F; Ramesh J; Kumar RS; Shen X; Ren J; Devendra S; Dorschel A; Wu M; Barrera I; Tabari A; Hu K; Haque N; Yambayev I; Li S; Kumar A; Behera TR; McDonough G; Furuichi M; Xifaras M; Lu T; Alhayaza RM; Miyabayashi K; Fan Q; Ajay AK; Zhou J
    Kidney Int; 2020 Nov; 98(5):1225-1241. PubMed ID: 32610050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of alpha-integrin subunits in fetal polycystic kidney diseases.
    Daïkha-Dahmane F; Narcy F; Dommergues M; Lacoste M; Beziau A; Gubler MC
    Pediatr Nephrol; 1997 Jun; 11(3):267-73. PubMed ID: 9203171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glis2 is an early effector of polycystin signaling and a target for therapy in polycystic kidney disease.
    Zhang C; Rehman M; Tian X; Pei SLC; Gu J; Bell TA; Dong K; Tham MS; Cai Y; Wei Z; Behrens F; Jetten AM; Zhao H; Lek M; Somlo S
    Nat Commun; 2024 May; 15(1):3698. PubMed ID: 38693102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender-Dependent Phenotype in Polycystic Kidney Disease Is Determined by Differential Intracellular Ca
    Talbi K; Cabrita I; Schreiber R; Kunzelmann K
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34199520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gα12 is required for renal cystogenesis induced by Pkd1 inactivation.
    Wu Y; Xu JX; El-Jouni W; Lu T; Li S; Wang Q; Tran M; Yu W; Wu M; Barrera IE; Bonventre JV; Zhou J; Denker BM; Kong T
    J Cell Sci; 2016 Oct; 129(19):3675-3684. PubMed ID: 27505895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TAZ/Wnt-β-catenin/c-MYC axis regulates cystogenesis in polycystic kidney disease.
    Lee EJ; Seo E; Kim JW; Nam SA; Lee JY; Jun J; Oh S; Park M; Jho EH; Yoo KH; Park JH; Kim YK
    Proc Natl Acad Sci U S A; 2020 Nov; 117(46):29001-29012. PubMed ID: 33122431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.